Board certified in internal medicine and medical oncology, Dr. Rastogi specializes in the diagnosis, treatment, and prevention of breast cancer at Magee-Womens Hospital of UPMC. She serves as Senior Associate Medical Director and Vice-Chair for Medical Affairs with the National Surgical Breast and Bowel Project and as the protocol officer for phase 2 and phase 3 adjuvant and neoadjuvant breast cancer clinical trials. Conducting her own research with NSABP, Dr. Rastogi examined the risk for congestive heart failure in women who received the drug herceptin in combination with chemotherapy.